Clinical Trial Update: Concentration of S-1 Metabolites in Tear and Plasma of Patients Receiving TS-1

View source ↗

Summary

An ongoing pharmacokinetic study evaluating concentrations of S-1 metabolites in tear and plasma of gastric cancer patients treated with TS-1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• TS-1 (S-1) (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Gastric Cancer | Status: UNKNOWN